Back
Green Dot Corp. 10K Form
Buy
56
GDOT
Green Dot Corp.
Last Price:
$13.21
Seasonality Move:
-2.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | GDOT/Green Dot Corp. Quarterly |
| 2023-11-09 | 10Q | GDOT/Green Dot Corp. Quarterly |
| 2023-08-08 | 10Q | GDOT/Green Dot Corp. Quarterly |
| 2023-05-09 | 10Q | GDOT/Green Dot Corp. Quarterly |
| 2022-11-09 | 10Q | GDOT/Green Dot Corp. Quarterly |
| 2022-08-08 | 10Q | GDOT/Green Dot Corp. Quarterly |
Receive GDOT News And Ratings
See the #1 stock for the next 7 days that we like better than GDOT
GDOT Financial Statistics
Sales & Book Value
| Annual Sales: | $1.7B |
|---|---|
| Cash Flow: | $3.5M |
| Price / Cash Flow: | 7.5 |
| Annual Sales: | $16.48 |
| Price / Book: | 0.8 |
Profitability
| EPS (TTM): | -0.85010 |
|---|---|
| Net Income (TTM): | $-46.9M |
| Gross Margin: | $500.9M |
| Return on Equity: | -5.12% |
| Return on Assets: | -0.84% |
Green Dot Corp. Earnings Forecast
Key Green Dot Corp. Financial Ratios
-
The Gross Profit Margin over the past 18 years for GDOT is 29.06%.
-
The Selling, General & Administrative Expenses for GDOT have been equal to 34.07% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of GDOT is -1.55% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 11 years.
Green Dot Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Consumer Finance |
| Sector: | Financials |
| Current Symbol: | GDOT |
| CUSIP: | 39304D |
| Website: | greendot.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 0.54 |
| Quick Ratio: | 0.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 51.62 |
|---|---|
| Forward P/E Ratio: | 8.85 |
GDOT Technical Analysis vs Fundamental Analysis
Buy
56
Green Dot Corp. (GDOT)
is a Buy
Is Green Dot Corp. a Buy or a Sell?
-
Green Dot Corp. stock is rated a BuyThe current Green Dot Corp. [GDOT] share price is $13.19. The Score for GDOT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.